Results
1 -
10 of
34Brummelkamp, et al..
A shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors, Nature Chemical Biology, 2006 Miyazaki Masaki, Kawato Haruko, Naito Hiroyuki, Ikeda Masahiro, Miyazaki Masaya, Kitagawa Mayumi, Seki Takahiko, Fukutake Setsuko, Aonuma Masashi, Soga Tsunehiko.
Discovery of novel dihydroimidazothiazole derivatives as p53–MDM2 protein–protein interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships, Bioorganic & Medicinal Chemistry Letters, 2012 The Role of the Interaction of p53 and the MAPK Cascade in Controlling Neuronal Differentiation in the PC12 Cell Line, Neuroscience and Behavioral Physiology Apoptosis-induced effects of extract from Artemisia annua Linn?? by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells, BMC Complementary and Alternative Medicine Restoration of p53 Function by MDM2 Inhibition: Potential Strategy to Treat KSHV-Associated Malignancies, Molecular Basis for Therapy of AIDS-Defining Cancers High Content Screening Biosensor Assay to Identify Disruptors of p53?hDM2 Protein-Protein Interactions, Protein-Protein Interactions Monitoring Ligand Modulation of Protein?Protein Interactions by Chemical Cross-Linking and High-Mass MALDI Mass Spectrometry, Chemical Proteomics Crosstalk Between Mdm2, p53 and HIF1-??: Distinct Responses to Oxygen Stress and Implications for Tumour Hypoxia, Mutant p53 and MDM2 in Cancer How Nutlin-3 disrupts the MDM2?p53 interaction: a theoretical investigation, Medicinal Chemistry Research The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40, Acta Diabetologica